Posts by Julien Feyen

SignPost was accepted into Newchip”‘s renowned global accelerator program. Designed to provide all the skills and tools seed-stage founders need to rapidly fund, build and scale their companies, past accelerator cohorts averaged more than 17.5 times the average funding amount. “Newchip evaluates a vast and diverse number of seed-stage companies from around the globe, selecting…

GENEVA (Reuters) –Breast cancer has overtaken lung cancer as the most common form of the disease, accounting for nearly 12% of new cases each year worldwide, the World Health Organization said on Tuesday. “For the first time, breast cancer now constitutes the most commonly occurring cancer globally,” Andre Ilbawi, a cancer specialist at the WHO,…

January 7, 2021 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced molecular diagnostic test to identify invasive breast cancer, announced today that Mr. Peter Blaney, Chief Executive Officer, will present at the 2021 BioConnect Conference hosted by H.C. Wainwright. Registered attendees can access the recorded presentation…

Dear Friends, As the holiday season begins, we hope that this update finds you and your family safe and healthy. With 2020 coming to a close, we wanted to take the time to review several positive milestones, advancements, and achievements as well as highlight new opportunities that are on the horizon for 2021. The summary…

Take a listen to Peter Attias interview with Dr. Raza . Peter Attia is a Canadian-American physician of Egyptian descent known for his medical practice that focuses on the science of longevity. He is also the first person to make the round-trip swim from Maui and Lanai. Dr. Azra Raza is a physician, scientist, author,…